Graphene oxide could revolutionize Kids' tooth fillings
NCT ID NCT07424053
First seen Feb 22, 2026 · Last updated Jun 23, 2026 · Updated 19 times
Summary
This study tests whether graphene oxide can successfully treat decayed baby teeth that need pulp therapy. 126 children will be split into groups receiving graphene oxide, standard materials like MTA or zinc oxide, or a lesion sterilization technique. The goal is to see which approach works best for saving the teeth and reducing pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY TEETH INDICATED FOR PULP THERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Graphene Oxide
What this could lead to
If successful, graphene oxide could become a new, effective option for treating decayed baby teeth, potentially improving outcomes and reducing procedure time.
What could go wrong
This is an early-stage trial with only 126 children, and graphene oxide has not been tested in this way before. It may not work better than existing treatments, and long-term safety is unknown.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.